IP Australia is open for business and continues to be committed to its customers and stakeholders. We are closely monitoring the latest information about the Novel Coronavirus (COVID-19) outbreak. Please refer to the Business continuity and the Coronavirus disease (COVID-19) outbreak pagelast updated 18 January 2021 for the most up to date information. We acknowledge these are challenging and uncertain times for everyone.
For information on new government support for business see Business.gov.au.
Economic Analysis of the Impact of Isolated Human Gene Patents
Date of Publication:
Wednesday, May 1, 2013
This report fills key gaps in the existing literature to review the economic impact of isolated human gene patents — their impact on incentives and disincentives to undertake and commercialise research.